Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overviewAll 13F holders of AVXLFull Q2 2026 holdings

Shares (Q2 2026)
329,115
Value
$852.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AVXL by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026329,115$852.4K<0.1%−230,320−41.2%ReducedHolders
Q1 2026559,435$1.72M<0.1%+445,696+391.9%AddedHolders
Q4 2025113,739$404.9K<0.1%−81,986−41.9%ReducedHolders
Q3 2025195,725$1.74M<0.1%−126,480−39.3%ReducedHolders
Q2 2025322,205$2.97M<0.1%+321,731+67,875.7%AddedHolders
Q1 2025474$4.07K<0.1%−240,432−99.8%ReducedHolders
Q4 2024240,906$2.59M<0.1%+215,381+843.8%AddedHolders
Q3 202425,525$145.0K<0.1%−421,313−94.3%ReducedHolders
Q2 2024446,838$1.89M<0.1%+446,834+11,170,850.0%AddedHolders
Q1 20244$20<0.1%−273,306−100.0%ReducedHolders
Q4 2023273,310$2.54M<0.1%−301,797−52.5%ReducedHolders
Q3 2023575,107$3.77M<0.1%+531,449+1,217.3%AddedHolders
Q2 202343,658$354.9K<0.1%+42,400+3,370.4%AddedHolders
Q1 20231,258$10.8K<0.1%−191,781−99.3%ReducedHolders
Q4 2022193,039$1.79M<0.1%−274,867−58.7%ReducedHolders
Q3 2022467,906$4.83M<0.1%−231,813−33.1%ReducedHolders
Q2 2022699,719$7.00M<0.1%+471,144+206.1%AddedHolders
Q1 2022228,575$2.81M<0.1%+195,197+584.8%AddedHolders
Q4 202133,378$579.0K<0.1%−33,325−50.0%ReducedHolders
Q3 202166,703$1.20M<0.1%+34,374+106.3%AddedHolders
Q2 202132,329$739.0K<0.1%−6,894−17.6%ReducedHolders
Q1 202139,223$586.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.